Bookmarks

Hi Everyone,

I just wanted to inform you of the recent release of the 2nd H3Africa ELSI RFA and encourage all who are eligible to apply. Feel free to contact me if you have questions.

Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01)
(RFA-RM-13-005)
The Common Fund/Office of Strategic Coordination
Application Receipt Date(s): June 19, 2013 and March 19, 2014

Thanks,

Ebony

Ebony Bookman, Ph.D.

Program Director

Division of Genomic Medicine

National Human Genome Research Institute

National Institutes of Health

530 Davis Drive Room 3130

Morrisville, NC 27560

919-541-0367 phone

919-541-2843 fax

ebony.bookman@nih.gov

A call for abstracts from China

Xuetao Cao a, Helena Hui Wang b, William Summerskill c, Selina Lo b, Richard Horton c

The China Academy of Medical Sciences (CAMS) and The Lancet family of journals invite abstract submissions from China for The Lancet-CAMS Health Summit, which will be held in Beijing, China on Oct 30—31, 2015. This multidisciplinary event will document the rapid progress and high quality research of China's health research community. Submissions are invited from all aspects of health science including, but not limited to: clinical medicine, translational medicine, public health, global health, health policy, the environment and ecological systems and health, and medical education.

The core of the event will consist of keynote presentations from leaders in China and elsewhere, and will include selected abstracts. After peer review, accepted abstracts will be edited and published online and in a conference booklet by The Lancet. Work completed outside China can be submitted, but only abstracts relevant to China's health science will be considered. The two best oral presentations, two best posters, and two best young investigators (aged 45 years or younger) will receive awards during the event.

The language of the conference will be English and abstracts should be written in English, up to 300 words in length, and with no references, tables, or figures. Submissions should include the following sections: background (including context and aim); methods; findings; and interpretation. Please also include a non-declamatory title (including a study descriptor—eg, randomised controlled trial); names, titles, highest degrees, and affiliations of authors; postal and email addresses for the corresponding author; any funding received (if none, please state this); and a brief summary of the contributions of each author and any competing interests. Guidelines are available on The Lancet's website.

Please submit your abstract as a Word document via The Lancet's online submission system no later than April 30, 2015, stating in your covering letter that the submission is in response to this call for abstracts from China. Following peer review by The Lancet, participants will be informed of acceptance of abstracts for oral or poster presentation by June 30, 2015.